Compare Okta, Inc. (OKTA) vs Relay Therapeutics Inc. Common Stock (RLAY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Okta, Inc. vs Relay Therapeutics Inc. Common Stock — how do they compare? Okta, Inc. trades at $224.46 (market cap $38.50B), while Relay Therapeutics Inc. Common Stock trades at $17.62 (market cap $3.82B). The key difference: Okta, Inc. is far larger — about 10.1× Relay Therapeutics Inc. Common Stock's market cap, and Okta, Inc. is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Okta, Inc. for 44 Days and Relay Therapeutics Inc. Common Stock for 0 Days on average.
| OKTA | RLAY | |
|---|---|---|
Market Cap | $38.50B | $3.82B |
Volume | 2,479,621 | 4,332,079 |
Sector | Technology | Health |
52-Week High | $220.21 | $20.75 |
52-Week Low | $62.93 | $6.03 |
Typical Hold Time | 44 Days | 0 Days |
Enterprise Value | $36.25B | $2.93B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
OKTA trades at $218.00, down slightly by 0.31% on the day, with a bullish technical signal from moving averages and strong quarterly earnings beats. The company reported a net income of $28 million in 2025, marking a significant turnaround from previous losses, while revenue grew to $2.61 billion. Recent news highlights its AI agent security initiatives, including the Blueprint Alliance unveiled at Oktane 2026.
Outlook remains positive with robust analyst support (73.58% buy ratings) and a consensus price target of $201.30, though high valuation ratios and overbought RSI readings pose near-term risks. Long-term growth is supported by identity management demand and AI positioning, but competition and execution challenges are key investor considerations.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →About Relay Therapeutics Inc. Common Stock
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →
